This compromise, addressing the concerns of both co-legislators, is acceptable for the Commission as it provides for clearer rules to deal with emerging diseases.
Taj kompromis, kojim se uzimaju u obzir bojazni obaju suzakonodavaca, Komisiji je prihvatljiv jer se njime predviđaju jasnija pravila za djelovanje u pogledu novih bolesti.